Mohamed M. Abdelhady

Mohamed M. Abdelhady

Auto-generated profile, based on publicly available information

Mohamed M. Abdelhady

Dermatology Department Faculty of Medicine/Cairo University Cairo Egypt

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Lasers in Surgery and Medicine
Verified
Journal Article
Open access
PDF file
STShereen O. Tawfic
Shereen O. Tawfic
DHDalia M. Abdel Halim
Dalia M. Abdel Halim
AAAmeera Albarbary
Ameera Albarbary
MAMohamed Abdelhady
Mohamed Abdelhady
Background: Melasma continues to be a disease that is difficult to treat with no fully satisfactory results. The role of a fractional CO2 laser in its treatment is controversial. The addition of tranexamic acid (TXA) might be helpful.Objectives: To assess the efficacy of a low‐power fractional CO2 laser alone versus its combination with tranexamic acid used either topically or intradermally for melasma treatment.Methods: A randomized comparative split‐face study included a total of thirty female patients with bilateral, symmetrical melasma. The whole face was subjected to treatment via a low‐power (12 Watts) fractional ablative CO2 laser. One side was randomly assigned to topical application of tranexamic acid solution after the session immediately or intradermal microinjection of tranexamic acid prior to the laser session. Sessions were conducted every 4–6 weeks for five consecutive sessions. Assessments were done using the melasma area severity index MASI score, melanin index (MI), and erythema index (EI) before sessions and 2 weeks after the final session.Results: After treatment, there was significant reduction in the MASI score on both sides of the face; the side treated with the fractional CO2 laser alone and the side treated with fractional CO2 laser combined with TXA (topically or intradermal injection) (P‐values 0.007, <0.001, and 0.016, respectively). MI was significantly lower on the side receiving fractional CO2 laser alone and the side receiving fractional CO2 laser combined with intradermal injection of TXA (P‐values <0.001 and 0.003, respectively), while the EI showed significant improvement only on the side receiving fractional CO2 laser alone (P‐value = 0.023). Although patients reported no differences in improvement on either treated side, the degree of improvement regarding the MASI score was better on the side receiving fractional CO2 laser alone. Regarding MI, the degree of improvement was higher on the side receiving fractional CO2 laser combined with intradermal injection of TXA than on the side receiving fractional CO2 laser alone; however, this improvement did not reach statistical significance. Minimal complications occurred in the form of mild pain.Conclusion: A low‐power fractional CO2 laser is an effective, safe treatment for melasma. However, the addition of tranexamic acid (either topically or intradermally) to a fractional CO2 laser should be further studied. Lasers Surg. Med. 51:27–33, 2019.

3 February 2017 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
MEMohamed EL-Komy
Mohamed EL-Komy
AHAkmal Hassan
Akmal Hassan
ATAmira Tawdy
Amira Tawdy
MSMohamed Solimon
Mohamed Solimon
MHMohamed Abdel Hady
Mohamed Abdel Hady

2 August 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ARAndreas Recke
Andreas Recke
SKSarah Konitzer
Sarah Konitzer
SLSusanne Lemcke
Susanne Lemcke
MFMiriam Freitag
Miriam Freitag
NSNele Maxi Sommer
Nele Maxi Sommer
TGthe German AIBD Genetic Study Group
the German AIBD Genetic Study Group
IgG3 is the IgG subclass with the strongest effector functions among all four IgG subclasses and the highest degree of allelic variability among all constant immunoglobulin genes. Due to its genetic position, IgG3 is often the first isotype an antibody switches to before IgG1 or IgG4. Compared with the other IgG subclasses, it has a reduced half-life which is probably connected to a decreased affinity to the neonatal Fc receptor (FcRn). However, a few allelic variants harbor an amino acid replacement of His435 to Arg that reverts the half-life of the resulting IgG3 to the same level as the other IgG subclasses. Because of its functional impact, we hypothesized that the p.Arg435His variation could be associated with susceptibility to autoantibody-mediated diseases like pemphigus vulgaris (PV) and bullous pemphigoid (BP). Using a set of samples from German, Turkish, Egyptian, and Iranian patients and controls, we were able to demonstrate a genetic association of the p.Arg435His variation with PV risk, but not with BP risk. Our results suggest a hitherto unknown role for the function of IgG3 in the pathogenesis of PV.

1 March 2019 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
RHRania Abdel Hay
Rania Abdel Hay
RHRehab Hegazy
Rehab Hegazy
MHMohamed Abdel Hady
Mohamed Abdel Hady
NSNoha Saleh
Noha Saleh
Background: Combined azelaic acid (AA) and salicylic acid (SA) has not been previously used for acne. Objective: To compare the efficacy of this combination versus trichloroacetic acid (TCA) 25% peel in acne. Methods: 34 patients were included in this trial. Patients received four sessions two-weeks apart. The combined solution was applied to one side of the face while TCA was applied to the other. Our outcomes were physician-reported clinical improvement, dermoscopic assessment of the erythema and patient's satisfaction. Results: After 2 sessions, a significant clinical improvement was observed in non-inflammatory lesions in the TCA treated side treated TCA and in inflammatory lesions in the SA/AA treated side. At the end, both modalities led to significant improvement, with no significant difference in between. Patients reported more discomfort with the TCA treated side. There was no significant different clinical improvement in both treated sides as regards SPT. Erythema improved in both sides. Patients were more satisfied by the SA/AA treated side. Conclusion: Chemical peeling is effective in controlling mild-moderate acne in SPT III-IV. Combined SA 20% and AA 20% is recommended at early stage of treatment if patients have more inflammatory lesions, while TCA is recommended if patients have more non-inflammatory lesions.

28 March 2019 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
YBYosra Bejaoui
Yosra Bejaoui
MWMareike Witte
Mareike Witte
MAMohamed Abdelhady
Mohamed Abdelhady
MEMohammad Eldarouti
Mohammad Eldarouti
NANermeen M. A. Abdallah
Nermeen M. A. Abdallah
SISaleh M. Ibrahim
Saleh M. Ibrahim

18 November 2014 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
OHO. Haase
O. Haase
HMH. Mosaad
H. Mosaad
MEM.A. Eldarouti
M.A. Eldarouti
AEA.Z. Elramly
A.Z. Elramly
NSN. Samir
N. Samir
SISaleh M. Ibrahim
Saleh M. Ibrahim